Are you a Canadian Licensed Producer (LP) looking to enter the European market? To sell in the EU, your cannabis products must meet EU-GMP standards. This requires converting your current GACP certification to EU-GMP, and we’re here to make it happen!
Why Target Europe?
- Germany is Leading the Market: Germany is the fastest-growing medical cannabis market worldwide. Nearly 50% of medical cannabis in Germany is imported from Canada, with demand expected to reach 100 tonnes by 2024.
- Competitive Edge: The European market is rapidly expanding. Now is the time to secure your place before the competition intensifies.
What We Offer:
- Cost-Effective Conversion: Our North Macedonia facility provides an affordable, high-quality conversion of your GACP-certified flower into EU-GMP-certified products.
- Seamless Process: We ensure that from initial processing to final packaging, your products meet all EU-GMP standards—guaranteeing safety, consistency, and purity.
- Market Access: EU-GMP certification unlocks lucrative opportunities across Europe, turning surplus stock into profitable ventures.
New Garden Pharma is here to help you navigate the EU market. |
